Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)
Use of Autologous Stem/Stromal Cells in Chronic Lung Disorders: Obstructive (COPD) and Restrictive (RLD)
Sponsor: Healeon Medical Inc
This PHASE1 trial investigates COPD and Respiratory Insufficiency and is currently suspended. Healeon Medical Inc leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Suspended PHASE1
-
Oct 2024 — Sep 2025 [monthly]
Suspended PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Suspended PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Suspended PHASE1
-
Apr 2022 — Jul 2024 [monthly]
Suspended PHASE1
▶ Show 6 earlier versions
-
Dec 2021 — Apr 2022 [monthly]
Suspended PHASE1
-
Feb 2021 — Dec 2021 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE1
Status: Enrolling By Invitation → Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Enrolling By Invitation PHASE1
-
May 2019 — Dec 2019 [monthly]
Enrolling By Invitation PHASE1
First recorded
Apr 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Healeon Medical Inc
- Robert W. Alexander, MD
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Roatán, Honduras
- • Stevensville, United States